3T Biosciences is a series a startup. 1 investor tracked on Brouky Intelligence. Status: possibledead. Data sourced from Brouky Intelligence.
About
3T Biosciences is a company focused on discovering and developing novel therapies for cancer treatment. They leverage their 3T-Trace platform to identify and target cancer-specific antigens, aiming to develop personalized immunotherapies.
Stage
series-a
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky